Evidence map›Paper›PMID 30652671›Full record

ArticleThe American journal of tropical medicine and hygiene2019

Clinical Indicators of Fatal Dengue in Two Endemic Areas of Colombia: A Hospital-Based Case-Control Study.

Elsa M Rojas, Víctor M Herrera, María C Miranda, Diana Patricia Rojas, Adriana M Gómez, Christian Pallares, Sara M Cobos, Lissethe Pardo, Margarita Gélvez, Andrés Páez and 4 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Illustrated histopathological features of fatal dengue cases in Colombia.Biomedica : revista del Instituto Nacional de Salud · 2020
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Elsa M RojasCenter for Epidemiological Research, Universidad Industrial de Santander-UIS, Bucaramanga, Colombia.
Víctor M HerreraCenter for Epidemiological Research, Universidad Industrial de Santander-UIS, Bucaramanga, Colombia.
María C MirandaCenter for Epidemiological Research, Universidad Industrial de Santander-UIS, Bucaramanga, Colombia.
Diana Patricia RojasDepartment of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida.
Adriana M GómezCenter for Epidemiological Research, Universidad Industrial de Santander-UIS, Bucaramanga, Colombia.
Christian PallaresHospital Universitario del Valle, Cali, Colombia.
Sara M CobosHospital Universitario del Valle, Cali, Colombia.
Lissethe PardoInstituto Nacional de Salud, Bogotá, Colombia.
Margarita GélvezCenter for Epidemiological Research, Universidad Industrial de Santander-UIS, Bucaramanga, Colombia.
Andrés PáezInstituto Nacional de Salud, Bogotá, Colombia.
Julio C MantillaDepartment of Pathology, Universidad Industrial de Santander-UIS, Bucaramanga, Colombia.
Anilza BoneloEmerging Viruses and Disease-VIREM, Universidad del Valle, Cali, Colombia.
Edgar ParraInstituto Nacional de Salud, Bogotá, Colombia.
Luis A VillarCenter for Epidemiological Research, Universidad Industrial de Santander-UIS, Bucaramanga, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to the World Health Organization, 98% of fatal dengue cases can be prevented; however, endemic countries such as Colombia have recorded higher case fatality rates during recent epidemics. We aimed to identify the predictors of mortality that allow risk stratification and timely intervention in patients with dengue. We conducted a hospital-based, case-control (1:2) study in two endemic areas of Colombia (2009-2015). Fatal cases were defined as having either 1) positive serological test (IgM or NS1), 2) positive virological test (RT-PCR or viral isolation), or 3) autopsy findings compatible with death from dengue. Controls (matched by state and year) were hospitalized nonfatal patients and had a positive serological or virological dengue test. Exposure data were extracted from medical records by trained staff. We used conditional logistic regression (adjusting for age, gender, disease's duration, and health-care provider) in the context of multiple imputation to estimate exposure to case-control associations. We evaluated 110 cases and 217 controls (mean age: 35.0 versus 18.9; disease's duration pre-admission: 4.9 versus 5.0 days). In multivariable analysis, retro-ocular pain (odds ratios [OR] = 0.23), nausea (OR = 0.29), and diarrhea (OR = 0.19) were less prevalent among fatal than nonfatal cases, whereas increased age (OR = 2.46 per 10 years), respiratory distress (OR = 16.3), impaired consciousness (OR = 15.9), jaundice (OR = 32.2), and increased heart rate (OR = 2.01 per 10 beats per minute) increased the likelihood of death (AUC: 0.97, 95% confidence interval: 0.96, 0.99). These results provide evidence that features of severe dengue are associated with higher mortality, which strengthens the recommendations related to triaging patients in dengue-endemic areas.

Indexed as

AdolescentAdultAntibodies, ViralCase-Control StudiesColombiaDengue VirusDiarrheaEndemic DiseasesFemaleHeadacheHumansImmunoglobulin MJaundiceLogistic ModelsMaleMiddle AgedAntibodies, ViralImmunoglobulin M

Identifiers

PMID30652671
PMCPMC6367622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.